Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

The economic burden of obesity in 4 south-eastern European countries associated with obesity-related co-morbidities

K. Athanasakis, C. Bala, A. Kokkinos, G. Simonyi, KH. Karoliová, A. Basse, M. Bogdanovic, M. Kang, K. Low, A. Gras

. 2024 ; 24 (1) : 354. [pub] 20240319

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24006698

OBJECTIVE: To provide an assessment of the cost burden of obesity across a spectrum of obesity-related comorbidities (ORCs) for four countries in South-Eastern Europe (SEE). METHODS: A micro-costing analysis from the public payer perspective was conducted to estimate direct healthcare costs associated with ten obesity-related comorbidities (ORCs) in Czech Republic, Greece, Hungary, and Romania. A survey was administered to obtain healthcare resource use and unit cost data. Cost estimates were validated by local steering committees which comprised at least one public sector clinician and a panel of independent industry experts. RESULTS: Chronic kidney disease and cardiovascular diseases were the costliest ORCs across all 4 countries, where annual cost burden per ORC exceeded 1,500 USD per patient per year. In general, costs were driven by the tertiary care resources allocated to address treatment-related adverse events, disease complications, and associated inpatient procedures. CONCLUSIONS: Our findings confirm that the high prevalence of obesity and its comorbidities result in substantial financial burden to all 4 SEE public payers. By quantifying the burden of obesity from a public healthcare perspective, our study aims to support policy efforts that promote health education and promotion in combating obesity in the region.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24006698
003      
CZ-PrNML
005      
20240423155440.0
007      
ta
008      
240412s2024 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s12913-024-10840-4 $2 doi
035    __
$a (PubMed)38504302
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Athanasakis, Kostas $u University of West Attica, Athens, Greece
245    14
$a The economic burden of obesity in 4 south-eastern European countries associated with obesity-related co-morbidities / $c K. Athanasakis, C. Bala, A. Kokkinos, G. Simonyi, KH. Karoliová, A. Basse, M. Bogdanovic, M. Kang, K. Low, A. Gras
520    9_
$a OBJECTIVE: To provide an assessment of the cost burden of obesity across a spectrum of obesity-related comorbidities (ORCs) for four countries in South-Eastern Europe (SEE). METHODS: A micro-costing analysis from the public payer perspective was conducted to estimate direct healthcare costs associated with ten obesity-related comorbidities (ORCs) in Czech Republic, Greece, Hungary, and Romania. A survey was administered to obtain healthcare resource use and unit cost data. Cost estimates were validated by local steering committees which comprised at least one public sector clinician and a panel of independent industry experts. RESULTS: Chronic kidney disease and cardiovascular diseases were the costliest ORCs across all 4 countries, where annual cost burden per ORC exceeded 1,500 USD per patient per year. In general, costs were driven by the tertiary care resources allocated to address treatment-related adverse events, disease complications, and associated inpatient procedures. CONCLUSIONS: Our findings confirm that the high prevalence of obesity and its comorbidities result in substantial financial burden to all 4 SEE public payers. By quantifying the burden of obesity from a public healthcare perspective, our study aims to support policy efforts that promote health education and promotion in combating obesity in the region.
650    _2
$a lidé $7 D006801
650    12
$a finanční stres $7 D000086522
650    12
$a podpora zdraví $7 D006293
650    _2
$a obezita $x epidemiologie $7 D009765
650    _2
$a náklady na zdravotní péči $7 D017048
650    _2
$a prevalence $7 D015995
650    _2
$a osobní újma zaviněná nemocí $7 D017281
655    _2
$a časopisecké články $7 D016428
700    1_
$a Bala, Cornelia $u University of Medicine and Pharmacy Iuliu Hațieganu, Cluj-Napoca, Romania
700    1_
$a Kokkinos, Alexander $u Medical School of the National, Kapodistrian University of Athens, Athens, Greece
700    1_
$a Simonyi, Gabor $u St. Imre University Teaching Hospital, Budapest, Hungary
700    1_
$a Karoliová, Klaudia Hálová $u Department of Obesitology, Institute of Endocrinology, Prague, Czech Republic
700    1_
$a Basse, Amaury $u Novo Nordisk, Copenhagen, Denmark
700    1_
$a Bogdanovic, Miodrag $u Novo Nordisk, Belgrade, Serbia. GMZB@novonordisk.com
700    1_
$a Kang, Malvin $u Ipsos Pte Ltd, Singapore, Singapore
700    1_
$a Low, Kaywei $u Ipsos Pte Ltd, Singapore, Singapore
700    1_
$a Gras, Adrien $u Ipsos Pte Ltd, Singapore, Singapore
773    0_
$w MED00008183 $t BMC health services research $x 1472-6963 $g Roč. 24, č. 1 (2024), s. 354
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38504302 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240412 $b ABA008
991    __
$a 20240423155436 $b ABA008
999    __
$a ok $b bmc $g 2080978 $s 1216465
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 24 $c 1 $d 354 $e 20240319 $i 1472-6963 $m BMC health services research $n BMC Health Serv Res $x MED00008183
LZP    __
$a Pubmed-20240412

Najít záznam

Citační ukazatele

Možnosti archivace